Compare, Analyse JUBILANT LIFE SCIENCES with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
TEVA PHARMA
Dec-13
JUBILANT LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8982,967-   
Low Rs6182,577-   
Sales per share (Unadj.) Rs572.01,702.7-  
Earnings per share (Unadj.) Rs36.2106.4-  
Cash flow per share (Unadj.) Rs59.5244.0-  
Dividends per share (Unadj.) Rs4.5093.11-  
Dividend yield (eoy) %0.63.4 17.7%  
Book value per share (Unadj.) Rs301.91,891.4-  
Shares outstanding (eoy) m159.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.6 81.4%   
Avg P/E ratio x20.926.1 80.3%  
P/CF ratio (eoy) x12.711.4 112.1%  
Price / Book Value ratio x2.51.5 171.2%  
Dividend payout %12.487.5 14.2%   
Avg Mkt Cap Rs m120,6942,350,758 5.1%   
No. of employees `0002.444.9 5.3%   
Total wages/salary Rs m19,2600-   
Avg. sales/employee Rs Th38,120.632,126.4 118.7%   
Avg. wages/employee Rs Th8,058.40-   
Avg. net profit/employee Rs Th2,414.32,006.9 120.3%   
INCOME DATA
Net Sales Rs m91,1081,443,919 6.3%  
Other income Rs m3570-   
Total revenues Rs m91,4661,443,919 6.3%   
Gross profit Rs m17,390395,418 4.4%  
Depreciation Rs m3,709116,713 3.2%   
Interest Rs m2,19828,361 7.8%   
Profit before tax Rs m11,840250,344 4.7%   
Minority Interest Rs m01,137 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,802-164,337 1.7%   
Tax Rs m3,268-3,056 -106.9%   
Profit after tax Rs m5,77090,201 6.4%  
Gross profit margin %19.127.4 69.7%  
Effective tax rate %27.6-1.2 -2,260.7%   
Net profit margin %6.36.2 101.4%  
BALANCE SHEET DATA
Current assets Rs m45,848975,218 4.7%   
Current liabilities Rs m20,897850,472 2.5%   
Net working cap to sales %27.48.6 317.0%  
Current ratio x2.21.1 191.3%  
Inventory Days Days5791 62.5%  
Debtors Days Days5196 53.1%  
Net fixed assets Rs m65,498471,616 13.9%   
Share capital Rs m1593,554 4.5%   
"Free" reserves Rs m47,9300-   
Net worth Rs m48,0891,603,920 3.0%   
Long term debt Rs m42,429738,308 5.7%   
Total assets Rs m114,6853,299,818 3.5%  
Interest coverage x6.49.8 65.0%   
Debt to equity ratio x0.90.5 191.7%  
Sales to assets ratio x0.80.4 181.6%   
Return on assets %6.93.6 193.4%  
Return on equity %12.05.6 213.4%  
Return on capital %12.44.9 251.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,8050-   
CASH FLOW
From Operations Rs m11,215230,086 4.9%  
From Investments Rs m-10,118-81,529 12.4%  
From Financial Activity Rs m6,574-276,004 -2.4%  
Net Cashflow Rs m7,612-127,446 -6.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare JUBILANT LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare JUBILANT LIFE SCIENCES With: WOCKHARDT  SHASUN PHARMA  NATCO PHARMA  TORRENT PHARMA  AJANTA PHARMA  



Today's Market

Indian Indices Trade on a Volatile Note; Healthcare and Banking Stocks Witness Buying(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading mixed with stocks in the metal sector and IT sector.

Related Views On News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 22, 2019 02:53 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS